This retrospective study examined lipid-lowering therapy treatment rates from 2000 to 2001 using the Ingenix LabRx Database. Patients with multiple risk factors without coronary heart disease were identified based on ...This retrospective study examined lipid-lowering therapy treatment rates from 2000 to 2001 using the Ingenix LabRx Database. Patients with multiple risk factors without coronary heart disease were identified based on the presence of ≥2 of the following: men ≥45 years, women ≥55 years, hypertension, high-density lipoprotein cholesterol < 40mg/dl, total cholesterol ≥200 mg/dl, or obesity. Lipid treatment rates were estimated among those needing therapy(defined as low-density lipoprotein cholesterol ≥130 mg/dl or currently receiving lipid-lowering therapy). The overall lipid-lowering therapy treatment rate was 38%and the estimated lipid treatment gap(percent needing treatment who were not receiving it) was 62%.展开更多
文摘This retrospective study examined lipid-lowering therapy treatment rates from 2000 to 2001 using the Ingenix LabRx Database. Patients with multiple risk factors without coronary heart disease were identified based on the presence of ≥2 of the following: men ≥45 years, women ≥55 years, hypertension, high-density lipoprotein cholesterol < 40mg/dl, total cholesterol ≥200 mg/dl, or obesity. Lipid treatment rates were estimated among those needing therapy(defined as low-density lipoprotein cholesterol ≥130 mg/dl or currently receiving lipid-lowering therapy). The overall lipid-lowering therapy treatment rate was 38%and the estimated lipid treatment gap(percent needing treatment who were not receiving it) was 62%.
